Coronavirus Disease 2019 (COVID-19) vaccine by China National Biotec Group for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval

Coronavirus Disease 2019 (COVID-19) vaccine is under clinical development by China National Biotec Group and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Telix announces Canada approval for Illuccix label expansion

Illuccix is used for PET imaging to detect PSMA-positive lesions in male prostate cancer patients. Credit: Korawat photo shoot/Shutterstock. Health Canada has expanded the approved

October 7, 2024

MedPod Today: Residency Application Updates; Doc Discipline; Vacation and Burnout

The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody. Welcome to MedPod Today, the podcast series where MedPage Today reporters share

January 20, 2024

Inovalon and MEDITECH Alliance Partner to Streamline Revenue Cycle Management

What You Should Know: – Inovalon, an innovator in cloud-based healthcare data solutions, announced a strategic partnership with the MEDITECH Alliance. – The strategic collaboration

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.